100
Participants
Start Date
June 14, 2017
Primary Completion Date
March 10, 2020
Study Completion Date
March 10, 2020
Main Study
The pharmacist will participate in the management of repeat prescribing and undertake medication reviews (which will address high risk prescribing and potentially inappropriate prescribing, deprescribing and cost-effective and generic prescribing) with adult patients. Pharmacists will also provide prescribing advice regarding the use of preferred drugs, undertake clinical audits, join practice team meetings and facilitate practice-based education. Throughout the six-month intervention period, anonymised practice-level medication (e.g. medication changes) and cost data will be collected.
PROM Study
For this, a sub-set of patients (n=200) aged ≥65 years on ≥10 repeat medicines will be recruited and invited to a medication review with the pharmacist. PROMs and healthcare utilisation data will be collected using patient questionnaires and a six-week follow-up review with these patients will also be conducted.
Royal College of Surgeons in Ireland, Dublin
Health Service Executive, Ireland
OTHER
University of Dublin, Trinity College
OTHER
Royal College of Surgeons, Ireland
OTHER